Acadia Healthcare Co. (NASDAQ:ACHC) has earned a consensus rating of “Buy” from the fifteen ratings firms that are presently covering the company. Two equities research analysts have rated the stock with a hold recommendation and twelve have given a buy recommendation to the company. The average twelve-month target price among analysts that have updated their coverage on the stock in the last year is $75.00.

A number of brokerages have issued reports on ACHC. Jefferies Group reissued a “buy” rating on shares of Acadia Healthcare in a report on Sunday, July 17th. Robert W. Baird reaffirmed an “outperform” rating and issued a $69.00 price target on shares of Acadia Healthcare in a report on Tuesday, June 14th. RBC Capital Markets reaffirmed an “outperform” rating and issued a $78.00 price target (down previously from $86.00) on shares of Acadia Healthcare in a report on Monday, August 1st. Zacks Investment Research raised shares of Acadia Healthcare from a “sell” rating to a “hold” rating in a report on Monday, October 3rd. Finally, Leerink Swann reaffirmed an “outperform” rating and issued a $90.00 price target on shares of Acadia Healthcare in a report on Friday, July 15th.

Acadia Healthcare (NASDAQ:ACHC) traded down 2.21% during midday trading on Tuesday, hitting $46.39. The company had a trading volume of 390,363 shares. Acadia Healthcare has a 52 week low of $45.85 and a 52 week high of $74.77. The firm has a market capitalization of $4.06 billion, a P/E ratio of 24.78 and a beta of 0.86. The firm’s 50 day moving average is $50.18 and its 200-day moving average is $54.96.

Acadia Healthcare (NASDAQ:ACHC) last issued its earnings results on Friday, July 29th. The company reported $0.73 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.73. Acadia Healthcare had a net margin of 6.44% and a return on equity of 9.35%. The business had revenue of $756.50 million for the quarter, compared to analysts’ expectations of $752.57 million. During the same quarter in the previous year, the firm posted $0.57 EPS. The business’s revenue for the quarter was up 66.8% compared to the same quarter last year. On average, equities research analysts expect that Acadia Healthcare will post $2.63 EPS for the current fiscal year.

In other news, major shareholder Waud Capital Partners Iii, L.L sold 457,443 shares of the stock in a transaction dated Friday, September 16th. The shares were sold at an average price of $48.39, for a total transaction of $22,135,666.77. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, COO Ronald Morgan Fincher sold 8,800 shares of the stock in a transaction dated Monday, August 8th. The stock was sold at an average price of $52.56, for a total transaction of $462,528.00. Following the sale, the chief operating officer now owns 120,780 shares of the company’s stock, valued at $6,348,196.80. The disclosure for this sale can be found here. Company insiders own 17.20% of the company’s stock.

Several hedge funds have recently bought and sold shares of the company. Aperio Group LLC raised its stake in Acadia Healthcare by 39.2% in the first quarter. Aperio Group LLC now owns 6,032 shares of the company’s stock worth $332,000 after buying an additional 1,699 shares in the last quarter. Teachers Advisors Inc. raised its stake in Acadia Healthcare by 29.5% in the first quarter. Teachers Advisors Inc. now owns 342,061 shares of the company’s stock worth $18,851,000 after buying an additional 77,973 shares in the last quarter. Prudential Financial Inc. raised its stake in Acadia Healthcare by 98.2% in the first quarter. Prudential Financial Inc. now owns 94,340 shares of the company’s stock worth $5,199,000 after buying an additional 46,750 shares in the last quarter. BlackRock Fund Advisors raised its stake in Acadia Healthcare by 16.6% in the first quarter. BlackRock Fund Advisors now owns 776,809 shares of the company’s stock worth $42,810,000 after buying an additional 110,692 shares in the last quarter. Finally, BlackRock Institutional Trust Company N.A. raised its stake in Acadia Healthcare by 23.7% in the first quarter. BlackRock Institutional Trust Company N.A. now owns 1,657,465 shares of the company’s stock worth $91,343,000 after buying an additional 317,107 shares in the last quarter.

About Acadia Healthcare

Acadia Healthcare Company, Inc is a provider of behavioral healthcare services. The Company operates in two segments: U.S. Facilities and U.K. Facilities. The Company develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities and facilities providing outpatient behavioral healthcare services to serve the behavioral health and recovery needs of communities throughout the United States, the United Kingdom and Puerto Rico.

5 Day Chart for NASDAQ:ACHC

Receive News & Stock Ratings for Acadia Healthcare Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare Co. and related stocks with our FREE daily email newsletter.